Hemicellulase
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Hemicellulase
- DrugBank Accession Number
- DB15820
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Albazyme-10A
- Endo-1,4-beta-xylanase A
- Gammanase
- Gemmicellulase
- Hemicellulase
- Hemicellulase (aspergillus niger)
- Hemicellulase reg II
- Pulpzyme
- Xylavomarin
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image FLATON ENTERIK DRAJE, 30 ADET Hemicellulase (50 mg) + Ox bile extract (25 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg) Tablet, coated Oral BİLİM İLAÇ SAN. VE TİC. A.Ş. 1989-03-14 Not applicable Turkey FLATON ENTERIK DRAJE, 60 ADET Hemicellulase (50 mg) + Ox bile extract (25 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg) Tablet, coated Oral BİLİM İLAÇ SAN. VE TİC. A.Ş. 1989-03-14 Not applicable Turkey Stozyme Hemicellulase (10.42 1/1001) + Dimethicone (5.21 1/1001) + Ox bile extract (5.21 1/1001) + Pancrelipase (36.46 1/1001) Tablet Oral Chunwoo Pharmaceutical Co., Ltd. 2019-10-19 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Stozyme Hemicellulase (10.42 1/1001) + Dimethicone (5.21 1/1001) + Ox bile extract (5.21 1/1001) + Pancrelipase (36.46 1/1001) Tablet Oral Chunwoo Pharmaceutical Co., Ltd. 2019-10-19 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- S2MZZ5DR1O
- CAS number
- 9025-56-3
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, coated Oral Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 09, 2020 19:24 / Updated at September 11, 2020 12:08